CGF +0.78%: Released FY21 earnings this morning that were smack on expectations, both in terms of earnings for FY21 and guidance for FY22. Normalised pre-tax profit of $396m for FY21 will jump by ~15% over the coming 12 months if they meet the midpoint of stated guidance (pre-tax profit $430m-$480m) as continued strength in annuity sales (sales doubled in 2H21 to $2.4bn) underpin the ongoing turnaround in the business. Higher interest rates would help as would an uptick in funds management fees. CGF have had a difficult time through COVID having cut risk in their book at the lows, battling an extended period of super low interest rates plus now they’ve also lost another CEO just 2.5 years into a 5 year term, however there is value there trading on ~14x earnings that are growing, just a few warts as well!
scroll
Question asked
Question asked
Question asked
Question asked
Buy Hold Sell: The best and worst performers of FY25
Close
Friday 4th July – Dow up +344pts, SPI up +27pts
Close
Thursday 3rd July – ASX -42pts, PME, NWH, GLF
Close
MM is neutral CGF, seeing some value around $5.86
Add To Hit List
Related Q&A
How does MM see Fortescue (FMG) trading through 2022?
Picking a healthcare winner
Technical thoughts on CGF & HLS
Our view of Challenger (CGF)
Relevant suggested news and content from the site

Video
WATCH
Buy Hold Sell: The best and worst performers of FY25
James Gerrish & Henry Jennings

Podcast
LISTEN
Friday 4th July – Dow up +344pts, SPI up +27pts
Daily Podcast Direct from the Desk

Podcast
LISTEN
Thursday 3rd July – ASX -42pts, PME, NWH, GLF
Daily Podcast Direct from the Desk
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.